- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer ; volume:9 ; number:1 ; day:2 ; month:6 ; year:2017 ; pages:1-12 ; date:12.2017
Clinical epigenetics ; 9, Heft 1 (2.6.2017), 1-12, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Richter, Antje M.
- Contributor
-
Kiehl, Steffen
Köger, Nicole
Breuer, Janina
Stiewe, Thorsten
Dammann, Reinhard
SpringerLink (Online service)
- DOI
-
10.1186/s13148-017-0360-4
- URN
-
urn:nbn:de:1111-2017070110521
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Richter, Antje M.
- Kiehl, Steffen
- Köger, Nicole
- Breuer, Janina
- Stiewe, Thorsten
- Dammann, Reinhard
- SpringerLink (Online service)
Other Objects (12)
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
The tumor suppressive mir-148a is epigenetically inactivated in classical Hodgkin lymphoma
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
Regulation of the NF2 tumour suppressor Merlin
Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Computational identification of tumour suppressor protein p53 target genes
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
The tumor suppressive mir-148a is epigenetically inactivated in classical Hodgkin lymphoma
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
Regulation of the NF2 tumour suppressor Merlin
Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Computational identification of tumour suppressor protein p53 target genes
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
The tumor suppressive mir-148a is epigenetically inactivated in classical Hodgkin lymphoma
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
Regulation of the NF2 tumour suppressor Merlin
Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections